Financhill
Buy
86

FMED Quote, Financials, Valuation and Earnings

Last price:
$28.50
Seasonality move :
7.13%
Day range:
$28.36 - $28.54
52-week range:
$20.69 - $29.07
Dividend yield:
0.4%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
11.5K
Avg. volume:
7.5K
1-year change:
7.37%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
FMED
Fidelity Disruptive Medicine ETF
-- -- -- -- --
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
-- -- -- -- --
GDOC
Goldman Sachs Future Health Care Equity ETF
-- -- -- -- --
MEDI
Harbor Health Care ETF
-- -- -- -- --
TMED
Trimedyne
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
FMED
Fidelity Disruptive Medicine ETF
$28.54 -- -- -- $0.11 0.4% --
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
$19.77 -- -- -- $0.00 0% --
GDOC
Goldman Sachs Future Health Care Equity ETF
$36.37 -- -- -- $0.01 0.02% --
MEDI
Harbor Health Care ETF
$31.87 -- -- -- $0.13 0.31% --
TMED
Trimedyne
-- -- -- -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
FMED
Fidelity Disruptive Medicine ETF
-- 0.826 -- --
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
-- 1.710 -- --
GDOC
Goldman Sachs Future Health Care Equity ETF
-- 0.654 -- --
MEDI
Harbor Health Care ETF
-- 0.805 -- --
TMED
Trimedyne
-- 0.000 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
FMED
Fidelity Disruptive Medicine ETF
-- -- -- -- -- --
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
-- -- -- -- -- --
GDOC
Goldman Sachs Future Health Care Equity ETF
-- -- -- -- -- --
MEDI
Harbor Health Care ETF
-- -- -- -- -- --
TMED
Trimedyne
-- -- -- -- -- --

Fidelity Disruptive Medicine ETF vs. Competitors

  • Which has Higher Returns FMED or EKG?

    First Trust Nasdaq Lux Digi Health Solutions ETF has a net margin of -- compared to Fidelity Disruptive Medicine ETF's net margin of --. Fidelity Disruptive Medicine ETF's return on equity of -- beat First Trust Nasdaq Lux Digi Health Solutions ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FMED
    Fidelity Disruptive Medicine ETF
    -- -- --
    EKG
    First Trust Nasdaq Lux Digi Health Solutions ETF
    -- -- --
  • What do Analysts Say About FMED or EKG?

    Fidelity Disruptive Medicine ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Lux Digi Health Solutions ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity Disruptive Medicine ETF has higher upside potential than First Trust Nasdaq Lux Digi Health Solutions ETF, analysts believe Fidelity Disruptive Medicine ETF is more attractive than First Trust Nasdaq Lux Digi Health Solutions ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    FMED
    Fidelity Disruptive Medicine ETF
    0 0 0
    EKG
    First Trust Nasdaq Lux Digi Health Solutions ETF
    0 0 0
  • Is FMED or EKG More Risky?

    Fidelity Disruptive Medicine ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust Nasdaq Lux Digi Health Solutions ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock FMED or EKG?

    Fidelity Disruptive Medicine ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.4%. First Trust Nasdaq Lux Digi Health Solutions ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fidelity Disruptive Medicine ETF pays -- of its earnings as a dividend. First Trust Nasdaq Lux Digi Health Solutions ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FMED or EKG?

    Fidelity Disruptive Medicine ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Lux Digi Health Solutions ETF quarterly revenues of --. Fidelity Disruptive Medicine ETF's net income of -- is lower than First Trust Nasdaq Lux Digi Health Solutions ETF's net income of --. Notably, Fidelity Disruptive Medicine ETF's price-to-earnings ratio is -- while First Trust Nasdaq Lux Digi Health Solutions ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity Disruptive Medicine ETF is -- versus -- for First Trust Nasdaq Lux Digi Health Solutions ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FMED
    Fidelity Disruptive Medicine ETF
    -- -- -- --
    EKG
    First Trust Nasdaq Lux Digi Health Solutions ETF
    -- -- -- --
  • Which has Higher Returns FMED or GDOC?

    Goldman Sachs Future Health Care Equity ETF has a net margin of -- compared to Fidelity Disruptive Medicine ETF's net margin of --. Fidelity Disruptive Medicine ETF's return on equity of -- beat Goldman Sachs Future Health Care Equity ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FMED
    Fidelity Disruptive Medicine ETF
    -- -- --
    GDOC
    Goldman Sachs Future Health Care Equity ETF
    -- -- --
  • What do Analysts Say About FMED or GDOC?

    Fidelity Disruptive Medicine ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Goldman Sachs Future Health Care Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity Disruptive Medicine ETF has higher upside potential than Goldman Sachs Future Health Care Equity ETF, analysts believe Fidelity Disruptive Medicine ETF is more attractive than Goldman Sachs Future Health Care Equity ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    FMED
    Fidelity Disruptive Medicine ETF
    0 0 0
    GDOC
    Goldman Sachs Future Health Care Equity ETF
    0 0 0
  • Is FMED or GDOC More Risky?

    Fidelity Disruptive Medicine ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock FMED or GDOC?

    Fidelity Disruptive Medicine ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.4%. Goldman Sachs Future Health Care Equity ETF offers a yield of 0.02% to investors and pays a quarterly dividend of $0.01 per share. Fidelity Disruptive Medicine ETF pays -- of its earnings as a dividend. Goldman Sachs Future Health Care Equity ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FMED or GDOC?

    Fidelity Disruptive Medicine ETF quarterly revenues are --, which are smaller than Goldman Sachs Future Health Care Equity ETF quarterly revenues of --. Fidelity Disruptive Medicine ETF's net income of -- is lower than Goldman Sachs Future Health Care Equity ETF's net income of --. Notably, Fidelity Disruptive Medicine ETF's price-to-earnings ratio is -- while Goldman Sachs Future Health Care Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity Disruptive Medicine ETF is -- versus -- for Goldman Sachs Future Health Care Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FMED
    Fidelity Disruptive Medicine ETF
    -- -- -- --
    GDOC
    Goldman Sachs Future Health Care Equity ETF
    -- -- -- --
  • Which has Higher Returns FMED or MEDI?

    Harbor Health Care ETF has a net margin of -- compared to Fidelity Disruptive Medicine ETF's net margin of --. Fidelity Disruptive Medicine ETF's return on equity of -- beat Harbor Health Care ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FMED
    Fidelity Disruptive Medicine ETF
    -- -- --
    MEDI
    Harbor Health Care ETF
    -- -- --
  • What do Analysts Say About FMED or MEDI?

    Fidelity Disruptive Medicine ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Harbor Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity Disruptive Medicine ETF has higher upside potential than Harbor Health Care ETF, analysts believe Fidelity Disruptive Medicine ETF is more attractive than Harbor Health Care ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    FMED
    Fidelity Disruptive Medicine ETF
    0 0 0
    MEDI
    Harbor Health Care ETF
    0 0 0
  • Is FMED or MEDI More Risky?

    Fidelity Disruptive Medicine ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Harbor Health Care ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock FMED or MEDI?

    Fidelity Disruptive Medicine ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.4%. Harbor Health Care ETF offers a yield of 0.31% to investors and pays a quarterly dividend of $0.13 per share. Fidelity Disruptive Medicine ETF pays -- of its earnings as a dividend. Harbor Health Care ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FMED or MEDI?

    Fidelity Disruptive Medicine ETF quarterly revenues are --, which are smaller than Harbor Health Care ETF quarterly revenues of --. Fidelity Disruptive Medicine ETF's net income of -- is lower than Harbor Health Care ETF's net income of --. Notably, Fidelity Disruptive Medicine ETF's price-to-earnings ratio is -- while Harbor Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity Disruptive Medicine ETF is -- versus -- for Harbor Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FMED
    Fidelity Disruptive Medicine ETF
    -- -- -- --
    MEDI
    Harbor Health Care ETF
    -- -- -- --
  • Which has Higher Returns FMED or TMED?

    Trimedyne has a net margin of -- compared to Fidelity Disruptive Medicine ETF's net margin of --. Fidelity Disruptive Medicine ETF's return on equity of -- beat Trimedyne's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FMED
    Fidelity Disruptive Medicine ETF
    -- -- --
    TMED
    Trimedyne
    -- -- --
  • What do Analysts Say About FMED or TMED?

    Fidelity Disruptive Medicine ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Trimedyne has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity Disruptive Medicine ETF has higher upside potential than Trimedyne, analysts believe Fidelity Disruptive Medicine ETF is more attractive than Trimedyne.

    Company Buy Ratings Hold Ratings Sell Ratings
    FMED
    Fidelity Disruptive Medicine ETF
    0 0 0
    TMED
    Trimedyne
    0 0 0
  • Is FMED or TMED More Risky?

    Fidelity Disruptive Medicine ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Trimedyne has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock FMED or TMED?

    Fidelity Disruptive Medicine ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.4%. Trimedyne offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fidelity Disruptive Medicine ETF pays -- of its earnings as a dividend. Trimedyne pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FMED or TMED?

    Fidelity Disruptive Medicine ETF quarterly revenues are --, which are smaller than Trimedyne quarterly revenues of --. Fidelity Disruptive Medicine ETF's net income of -- is lower than Trimedyne's net income of --. Notably, Fidelity Disruptive Medicine ETF's price-to-earnings ratio is -- while Trimedyne's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity Disruptive Medicine ETF is -- versus -- for Trimedyne. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FMED
    Fidelity Disruptive Medicine ETF
    -- -- -- --
    TMED
    Trimedyne
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 18.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock